Guadecitabine (SGI-110) Offers Potential New Treatment Option for Myelodysplastic Syndromes, Phase 2 Study Finds
Keywords 1. Guadecitabine 2. Myelodysplastic Syndromes Treatment 3. Hypomethylating Agents 4. Phase 2 Clinical Trial…
Read MoreKeywords 1. Guadecitabine 2. Myelodysplastic Syndromes Treatment 3. Hypomethylating Agents 4. Phase 2 Clinical Trial…
Read MoreIntroduction Nonalcoholic fatty liver disease (NAFLD) is rapidly becoming a global health concern, paralleling the…
Read MoreAbstract The realm of medical education has witnessed a transformative leap with the inception of…
Read MoreKeywords 1. Postpartum depression 2. Chinese confinement practice 3. Doing the month 4. Maternal mental…
Read MoreIn Eastern Ethiopia, where progress concerning maternal health service utilization stagnates, a new qualitative study…
Read MoreSevere maternal morbidity (SMM) is a critical concern in obstetrics and public health, reflecting life-threatening…
Read More